| Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins P Raynal, HB Pollard Biochimica et Biophysica Acta (BBA)-Reviews on Biomembranes 1197 (1), 63-93, 1994 | 1381 | 1994 |
| The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway M Dance, A Montagner, JP Salles, A Yart, P Raynal Cellular signalling 20 (3), 453-459, 2008 | 384 | 2008 |
| A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation A Montagner, A Yart, M Dance, B Perret, JP Salles, P Raynal Journal of Biological Chemistry 280 (7), 5350-5360, 2005 | 233 | 2005 |
| A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor A Yart, M Laffargue, P Mayeux, S Chretien, C Peres, N Tonks, S Roche, ... Journal of Biological Chemistry 276 (12), 8856-8864, 2001 | 196 | 2001 |
| A function for phosphatidylinositol 3-kinase β (p85α-p110β) in fibroblasts during mitogenesis: requirement for insulin-and lysophosphatidic acid-mediated signal transduction S Roche, J Downward, P Raynal, SA Courtneidge Molecular and cellular biology 18 (12), 7119-7129, 1998 | 177 | 1998 |
| Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature ADR Serra-Nédélec, T Edouard, K Tréguer, M Tajan, T Araki, M Dance, ... Proceedings of the National Academy of Sciences 109 (11), 4257-4262, 2012 | 129 | 2012 |
| Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature ADR Serra-Nédélec, T Edouard, K Tréguer, M Tajan, T Araki, M Dance, ... Proceedings of the National Academy of Sciences 109 (11), 4257-4262, 2012 | 129 | 2012 |
| Reduced phosphatase activity of SHP‐2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1 N Hanna, A Montagner, WH Lee, M Miteva, M Vidal, M Vidaud, B Parfait, ... FEBS letters 580 (10), 2477-2482, 2006 | 129 | 2006 |
| Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature ADR Serra-Nédélec, T Edouard, K Tréguer, M Tajan, T Araki, M Dance, ... Proceedings of the National Academy of Sciences 109 (11), 4257-4262, 2012 | 128 | 2012 |
| Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation K Missy, V Van Poucke, P Raynal, C Viala, G Mauco, M Plantavid, H Chap, ... Journal of Biological Chemistry 273 (46), 30279-30286, 1998 | 119 | 1998 |
| An epidermal growth factor receptor/Gab1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid M Laffargue, P Raynal, A Yart, C Peres, R Wetzker, S Roche, B Payrastre, ... Journal of Biological Chemistry 274 (46), 32835-32841, 1999 | 116 | 1999 |
| A function for phosphoinositide 3-kinase β lipid products in coupling βγ to Ras activation in response to lysophosphatidic acid A Yart, S Roche, R Wetzker, M Laffargue, N Tonks, P Mayeux, H Chap, ... Journal of Biological Chemistry 277 (24), 21167-21178, 2002 | 115 | 2002 |
| Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen … T Edouard, JP Combier, A Nédélec, S Bel-Vialar, M Métrich, ... Molecular and Cellular Biology 30 (10), 2498-2507, 2010 | 112 | 2010 |
| Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancers Q Zhu, H Youn, J Tang, O Tawfik, K Dennis, PF Terranova, J Du, P Raynal, ... Oncogene 27 (33), 4569-4579, 2008 | 106 | 2008 |
| Effect of Dexamethasone on Prostaglandin Synthesis and on Lipocortin Status in Human Endothelial Cells: Inhibition of prostaglandin I2 synthesis occurring without alteration of … F Hullin, P Raynal, JMF Ragab-Thomas, J Fauvel, H Chap Journal of Biological Chemistry 264 (6), 3506-3513, 1989 | 105 | 1989 |
| Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway A Yart, H Chap, P Raynal Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2002 | 102 | 2002 |
| The adaptor protein Gab1 couples the stimulation of vascular endothelial growth factor receptor-2 to the activation of phosphoinositide 3-kinase M Dance, A Montagner, A Yart, B Masri, Y Audigier, B Perret, JP Salles, ... Journal of biological chemistry 281 (32), 23285-23295, 2006 | 83 | 2006 |
| Myeloid dysregulation in a human induced pluripotent stem cell model of PTPN11-associated juvenile myelomonocytic leukemia S Mulero-Navarro, A Sevilla, AC Roman, DF Lee, SL D’Souza, S Pardo, ... Cell reports 13 (3), 504-515, 2015 | 80 | 2015 |
| LEOPARD syndrome-associated SHP2 mutation confers leanness and protection from diet-induced obesity M Tajan, A Batut, T Cadoudal, S Deleruyelle, S Le Gonidec, ... Proceedings of the National Academy of Sciences 111 (42), E4494-E4503, 2014 | 69 | 2014 |
| Modulation of phosphoinositide 3-kinase activation by cholesterol level suggests a novel positive role for lipid rafts in lysophosphatidic acid signalling C Peres, A Yart, B Perret, JP Salles, P Raynal FEBS letters 534 (1-3), 164-168, 2003 | 64 | 2003 |
